Myriad Pharmaceuticals, Inc.
Myriad Pharmaceuticals, Inc. (MYRX) is a publicly traded company in the Unknown sector. Across all available filings, 12 corporate insiders have executed 68 transactions totaling $2.3M, demonstrating a bullish sentiment with $2.0M in net insider flow. The most recent transaction on Jan 18, 2013 involved a transaction of 7,500 shares valued at $8.0K.
MYRX Insider Activity Summary
Who Is Buying MYRX Stock?
No significant insider buying has been recorded for MYRX in the recent period.
Who Is Selling MYRX Stock?
No significant insider selling has been recorded for MYRX in the recent period.
Is Myriad Pharmaceuticals, Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for MYRX is bullish with an Insider Alignment Score of 92/100 and a net flow of $2.0M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
MYRX Frequently Asked Questions
Understanding MYRX Insider Activity
Insider trading at Myriad Pharmaceuticals, Inc. (MYRX) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 12 insiders are actively trading MYRX stock, having executed 68 transactions in the past 90 days. The most active insider is Jason Aryeh (Executive), who has made 29 transactions totaling $1.4M.
Related Tools
Track Myriad Pharmaceuticals, Inc. Insider Activity
Get notified when executives and directors at MYRX file new Form 4 transactions